XML 80 R57.htm IDEA: XBRL DOCUMENT v3.25.4
Share-based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted Average Assumptions Used To Estimate The Grant Date Fair Value of Options Granted
The fair value of each stock option or LTIP Unit granted is estimated on the date of grant using the Black-Scholes option pricing model based on historical information with the following weighted average assumptions for grants during the years ended December 31, 2025 and 2024 (there were no options granted during the year ended December 31, 2023).
202520242023
Dividend yield7.1 %5.5 %N/A
Expected life3.6 years7.5 yearsN/A
Risk-free interest rate3.58 %4.45 %N/A
Expected stock price volatility46.0 %45.0 %N/A
Summary of The Status of Stock Options And Changes During The Period
A summary of the status of the Company's stock options as of December 31, 2025, 2024, and 2023 and changes during the years ended December 31, 2025, 2024, and 2023 are as follows:
Year Ended December 31,
202520242023
Options OutstandingWeighted Average
Exercise Price		Options OutstandingWeighted Average
Exercise Price		Options
Outstanding		Weighted
Average
Exercise
Price
Balance at beginning of year333,897 $81.63 115,980 $103.52 313,480 $97.59 
Granted407,000 44.35 217,917 68.07 — — 
Lapsed or canceled— — — — (197,500)84.14 
Balance at end of year740,897 $61.66 333,897 $81.63 115,980 $103.52 
Options exercisable at end of year188,619 $91.12 115,980 $103.52 115,980 $103.52 
Schedule of Other Share-based Compensation, Activity
A summary of the Company's restricted stock as of December 31, 2025, 2024, and 2023 and changes during the years ended December 31, 2025, 2024, and 2023 are as follows:
Year Ended December 31,
202520242023
Balance at beginning of year4,449,709 4,089,174 3,758,174 
Granted91,926 371,285 337,350 
Canceled(9,635)(10,750)(6,350)
Balance at end of year4,532,000 4,449,709 4,089,174 
Vested during the year236,139 143,453 147,915 
Compensation expense recorded$15,077,198 $10,939,602 $7,766,055 
Total fair value of restricted stock granted during the year$4,206,695 $24,676,422 $15,789,540